Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06442046

Strengthening the Connections to Opportunities for Prevention Engagement

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.

Recruiting

Interested in participating?

Request Info

Key information

Age range

8 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Connecticut Children's

Hartford, Connecticut, 06106, United States

Location status: Recruiting

Location contact

Kevin Borrup, DrPH

CONTACT

Sharon Smith, MD

CONTACT

About this study

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) when they are determined to have high levels of violence exposure.

SCOPE seeks to decrease future violence exposure and increase resiliency of children with high levels of exposure to violence through Emergency Department (ED)-based case management and connections with community partners.

Hypothesis 1: VPET scores within the intervention group will show significant reductions across the study period. The percent of patients with positive VPET positive scores within the intervention group will show significant reductions from the expected 79% to 70% as compared to the control group that will have the expected 79%

Hypothesis 2: The Child and Youth Resilience Measure-Revised (CYRM) scores for the intervention group will increase by 10%, and will be significantly higher than the control group.

Hypothesis 3: At least 75% of the intervention group will be assessed as "positive" for having made a connection with community services.

Hypothesis 4: 90% of parents with children receiving case management will report being satisfied with the case management services and community connected services.

Hypothesis 5: Retention within the intervention group will be at or above 50%, with at least half of participants remaining engaged in the project.

Hypothesis 6: Compared to the control group, the intervention group will have fewer documented injuries and ED visits during the 12-month period post-enrollment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 8 years of age and not older than 17 years of age (until 18th birthday)
  • Hartford resident based on zip code of primary residence or parent report?
  • Accompanied by a parent or guardian who can provide consent
  • Capable of providing assent/consent
  • Able to provide consent in English or Spanish
  • Presenting at CT Children's during recruitment hours

Exclusion criteria

  • Patients whose primary complaint is for behavioral health
  • Patients in Connecticut Department of Children and Families (DCF) or police custody

Treatment and study plan

Active Case Management

Other

A case manager will work with families post-discharge to ensure that youth are connected to an appropriate community support. Case managers will also work with families to identify any social needs and provide support in accessing services as needed.

Treatment as Usual

Other

Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.

Primary outcomes

  1. Change from baseline violence exposure at 12 months

    Time frame: Baseline and months 3, 6, 9, and 12

    A reduction in exposure as measured using the Violence Prevention Emergency Tool (VPET) that provides a range from 0 to 21 with a 4 or more considered elevated.

Secondary outcomes

  1. Change in resilience score from baseline at 12 months

    Time frame: Baseline and months 3, 6, 9, and 12

    The Child and Youth Resilience Measure-Revised (CYRM) is a validated scale with resilience scores that range from 17 to 85 with a higher score indicating greater resilience.

  2. Difference in connections between intervention and control at 3-month intervals.

    Time frame: Quarterly measure at 0, 3, 6, 9, and 12 months

    A dichotomous yes/no variable answering the question of are you currently connected to services at a community agency?

  3. Level of satisfaction with case management services after 12 months of services

    Time frame: At 12-months of case management.

    Level of satisfaction with case management services as indicated along a 5-point scale from Not satisfied to Completely satisfied. Higher levels of satisfaction are related with other improved outcomes from baseline.

  4. Rate of re-injury in the intervention group compared to the control condition.

    Time frame: baseline, 3, 6, 9, 12 months

    Hospital documented injuries during the study period will be assessed on a quarterly schedule.

Study contacts

Contact information is provided by the study sponsor or research team.

Rebecca Beebe, PhD

CONTACT

[email protected]

Sharon Smith, MD

CONTACT

[email protected]

8605459295

Sponsors and collaborators

Lead sponsor

Kevin Borrup

Other

Collaborators

  • The Tow Foundation

Registry information

Official study title

Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE)

Acronym: SCOPE

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jun 4, 2024
Registry last updated
Sep 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.